Hongfei Lou

Hongfei Lou

Auto-generated profile, based on publicly available information

Hongfei Lou

Department of Otolaryngology, Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
MXMu Xian
Mu Xian
SMSiyuan Ma
Siyuan Ma
KWKuiji Wang
Kuiji Wang
HLHongfei Lou
Hongfei Lou
YWYang Wang
Yang Wang
CACezmi A. Akdis
Cezmi A. Akdis
The effect of air pollution-related particulate matter (PM) on epithelial barrier function and tight junction (TJ) expression in human nasal mucosa has not been studied to date. This study therefore aimed to assess the direct impact of PM with an aerodynamic diameter less than 2.5 μ (PM2.5) on the barrier function and TJ molecular expression of human nasal epithelial cells. Air-liquid interface cultures were established with epithelial cells derived from noninflammatory nasal mucosal tissue collected from patients undergoing paranasal sinus surgery. Confluent cultures were exposed to 50 or 100 μg/mL PM2.5 for up to 72 hours, and assessed for 1) epithelial barrier integrity as measured by transepithelial resistance (TER) and permeability of fluorescein isothiocyanate (FITC) 4 kDa; 2) expression of TJs using real-time quantitative polymerase chain reaction and immunofluorescence staining, and 3) proinflammatory cytokines by luminometric bead array or enzyme-linked immunosorbent assay. Compared to control medium, 50 and/or 100 μg/mL PM2.5-treatment 1) significantly decreased TER and increased FITC permeability, which could not be restored by budesonide pretreatment; 2) significantly decreased the expression of claudin-1 messenger RNA, claudin-1, occludin and ZO-1 protein; and 3) significantly increased production of the cytokines interleukin-8, TIMP metallopeptidase inhibitor 1 and thymic stromal lymphopoietin. Exposure to PM2.5 may lead to loss of barrier function in human nasal epithelium through decreased expression of TJ proteins and increased release of proinflammatory cytokines. These results suggest an important mechanism of susceptibility to rhinitis and rhinosinusitis in highly PM2.5-polluted areas.

1 April 2017 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
HLHongfei Lou
Hongfei Lou
JLJingning Lu
Jingning Lu
ECEun Byul Choi
Eun Byul Choi
MOMin Hee Oh
Min Hee Oh
MJMingeum Jeong
Mingeum Jeong
TZTao Zheng
Tao Zheng
Increased expression of Th22 cytokine IL-22 is a characteristic finding in atopic dermatitis (AD). However, the specific role of IL-22 in the pathogenesis of AD in vivo has yet to be elucidated. Consistent with observations in human AD, IL-22 was significantly increased in the AD skin of mice after epicutaneous sensitization to house dust mite allergen. Utilizing a skin-specific inducible transgenic system, we show in the present study that expression of IL-22 in the skin of mice caused an AD-like phenotype characterized by chronic pruritic dermatitis associated with Th2-biased local and systemic immune responses, downregulation of epidermal differentiation complex genes, and enhanced dermatitis upon epicutaneous allergen exposure. IL-22 potently induced the expression of gastrin-releasing peptide (GRP), a neuropeptide pruritogen, in dermal immune cells and sensory afferents and in their skin-innervating sensory neurons. IL-22 also differentially upregulated the expression of GRP receptor (GRPR) on keratinocytes of AD skin. The number of GRP+ cells in the skin correlated with the AD severity and the intensity of pruritus. IL-22 directly upregulated the expression of epithelial-derived type 2 cytokines (thymic stromal lymphopoietin and IL-33) and GRP in primary keratinocytes. Furthermore, GRP not only strongly induced thymic stromal lymphopoietin but it also increased the expression of IL-33 and GRPR synergistically with IL-22. Importantly, we found that the expression of GRP was strikingly increased in the skin of patients with AD. These results indicate that IL-22 plays important pathogenic roles in the initiation and development of AD, in part through inducing keratinocyte production of type 2 cytokines and activation of the GRP/GRPR pathway.

21 November 2022 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
Chengshuo WangChengshuo Wang
Chengshuo Wang
YBYixiao Bao
Yixiao Bao
JCJianjun Chen
Jianjun Chen
XCXiaoyang Chen
Xiaoyang Chen
LClei Cheng
lei Cheng
C(Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G)
Chinese Allergic Rhinitis Collaborative Research Group (C2AR2G)
Wang C, et al. Allergy Asthma Immunol Res. 2022 Nov;14(6):604-652. https://doi.org/10.4168/aair.2022.14.6.604

7 March 2022 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
SCShiru Cai
Shiru Cai
SXShenglong Xu
Shenglong Xu
HLHongfei Lou
Hongfei Lou
LZLuo Zhang
Luo Zhang

1 January 2020 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
ZLZheng Liu
Zheng Liu
JCJianjun Chen
Jianjun Chen
LClei Cheng
lei Cheng
HLHuabin Li
Huabin Li
SLShixi Liu
Shixi Liu
LZLuo Zhang
Luo Zhang
The current document is based on a consensus reached by a panel of experts from the Chinese Society of Allergy and the Chinese Society of Otorhinolaryngology-Head and Neck Surgery, Rhinology Group. Chronic rhinosinusitis (CRS) affects approximately 8% of Chinese adults. The inflammatory and remodeling mechanisms of CRS in the Chinese population differ from those observed in the populations of European descent. Recently, precision medicine has been used to treat inflammation by targeting key biomarkers that are involved in the process. However, there are no CRS guidelines or a consensus available from China that can be shared with the international academia. The guidelines presented in this paper cover the epidemiology, economic burden, genetics and epigenetics, mechanisms, phenotypes and endotypes, diagnosis and differential diagnosis, management, and the current status of CRS in China. These guidelines-with a focus on China-will improve the abilities of clinical and medical staff during the treatment of CRS. Additionally, they will help international agencies in improving the verification of CRS endotypes, mapping of eosinophilic shifts, the identification of suitable biomarkers for endotyping, and predicting responses to therapies. In conclusion, these guidelines will help select therapies, such as pharmacotherapy, surgical approaches and innovative biotherapeutics, which are tailored to each of the individual CRS endotypes.

7 February 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
HLHongfei Lou
Hongfei Lou
YHYanran Huang
Yanran Huang
YOYuhui Ouyang
Yuhui Ouyang
YZYuan Zhang
Yuan Zhang
LXLin Xi
Lin Xi
LZLuo Zhang
Luo Zhang